Abbvie Inc (ABBV) Stock: Analyzing the Market Value
Abbvie Inc (NYSE: ABBV) has a higher price-to-earnings ratio of 47.45x compared to its average ratio, The 36-month beta value for ABBV is at 0.58.
Abbvie Inc (NYSE: ABBV) has a higher price-to-earnings ratio of 47.45x compared to its average ratio, The 36-month beta value for ABBV is at 0.58.
The stock price of Abbvie Inc (NYSE: ABBV) has surged by 1.06 when compared to previous closing price of 164.66, but the company has seen
Abbvie Inc (NYSE: ABBV) has seen a decline in its stock price by -3.13 in relation to its previous close of 167.52. However, the company
Abbvie Inc (NYSE: ABBV)’s stock price has gone rise by 1.25 in comparison to its previous close of 167.90, however, the company has experienced a
Abbvie Inc (NYSE: ABBV) has a price-to-earnings ratio that is above its average at 66.45x. The stock has a 36-month beta value of 0.56. Opinions
© 2024, Powered by Smart TechOne
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.